title: Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan. ykonishi@kuhp.kyoto-u.ac.jp.|Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. ykonishi@kuhp.kyoto-u.ac.jp.
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Konishi
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
authors.forename: Kohei
authors.initials: K
authors.lastname: Tada
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Nishi
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
authors.forename: Kazunori
authors.initials: K
authors.lastname: Imada
mesh_terms: D064591:Allografts; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002871:Chromosome Banding; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D012074:Remission Induction; D019172:Transplantation Conditioning